HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

rituximab-alliinase conjugate

alliinase conjugated to the monoclonal antibody rituximab, which recognizes the CD20 antigen, and the resulting conjugate was targeted to CD20+ B chronic lymphocytic leukemia (B-CLL) and other B-cell lymphomas
Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Reisner, Yair: 1 article (02/2005)
2. Berrebi, Alain: 1 article (02/2005)
3. Miron, Talia: 1 article (02/2005)
4. Arditti, Fabian D: 1 article (02/2005)
5. Rabinkov, Aharon: 1 article (02/2005)
6. Mirelman, David: 1 article (02/2005)
7. Wilchek, Meir: 1 article (02/2005)

Related Diseases

1. B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
2. Neoplasms (Cancer)

Related Drugs and Biologics

1. allicin